The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Aspirin 300mg Effervescent tablets

Bayer LimitedPA1410/037/001

Main Information

Trade NameAspirin 300mg Effervescent tablets
Active SubstancesAspirin
Dosage FormEffervescent tablet
Licence HolderBayer Limited
Licence NumberPA1410/037/001

Group Information

ATC CodeN02BA Salicylic acid and derivatives
N02BA01 acetylsalicylic acid


License statusAuthorised
Licence Issued08/06/1976
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceGeneral sale in blister packs containing not more than 24 unit dosage forms. Retail sale through pharmacies only in blister packs containing not more than 50 unit dosage forms. The indications should be appropriate for self-diagnosis and self-treatment. Promotion to the general public only for indications appropriate for self-diagnosis and self-treatment. Aspirin containg medicinal products should not be administered to subjects under 16 years of age unless specifically indicated by a healthcare professional.
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back